Ken Ataka
Impact in
- Biotechnology top 5%
- Microbial Inactivation Methods
- Transgenic Plants and Applications
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
Papers in
- Genetics 3
- Virus-based gene therapy research 3
-
- Microbial Inactivation Methods 3
- Co-authors
- Fumitake Gejyo (7 shared papers)Hiroki Maruyama (5 shared papers)Jun‐ichi Miyazaki (4 shared papers)Noboru Higuchi (4 shared papers)Junichiro James Kazama (2 shared papers)Tomohiro Neichi (2 shared papers)F. Sakamoto (1 shared paper)Ikuo Imazeki (2 shared papers)
- Journals
- Gene Therapy (2 papers)The Nephron journals/Nephron journals (1 paper)Human Gene Therapy (1 paper)American Journal of Nephrology (1 paper)Kidney International (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Ken Ataka
8 papers receiving 341 citations
Peers
Comparison fields: 5 of 62
- Biotechnology 118
- Nephrology 62
- Genetics 62
- Hematology 23
- Molecular Biology 122
Countries citing papers authored by Ken Ataka
This map shows the geographic impact of Ken Ataka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Ataka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Ataka more than expected).
Fields of papers citing papers by Ken Ataka
This network shows the impact of papers produced by Ken Ataka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Ataka. The network helps show where Ken Ataka may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Ataka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 80 | |
| 2 | 2001 | 74 | |
| 3 | 2000 | 73 | |
| 4 | 2001 | 65 | |
| 5 | 2003 | 42 | |
| 6 | 2005 | 14 | |
| 7 | 2000 | 9 | |
| 8 | 2021 | 3 |
About Ken Ataka
Ken Ataka is a scholar working on Genetics, Biotechnology, Surgery, Molecular Biology and Nephrology, having authored 8 papers that have together received 360 indexed citations. Recurring topics across this work include Microbial Inactivation Methods (3 papers), Virus-based gene therapy research (3 papers), Muscle and Compartmental Disorders (2 papers), CRISPR and Genetic Engineering (2 papers), Dialysis and Renal Disease Management (2 papers), Health Systems, Economic Evaluations, Quality of Life (1 paper), Central Venous Catheters and Hemodialysis (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Biotechnology (118 citations), Nephrology (62 citations), Genetics (62 citations), Hematology (23 citations) and Molecular Biology (122 citations). Ken Ataka has collaborated with scholars based in Japan and United States. Frequent co-authors include Fumitake Gejyo, Hiroki Maruyama, Jun‐ichi Miyazaki, Noboru Higuchi, Junichiro James Kazama, Tomohiro Neichi, F. Sakamoto, Ikuo Imazeki, Makoto Sugawa and Yumi Ito. Their work appears in journals such as Gene Therapy, The Nephron journals/Nephron journals, Human Gene Therapy, American Journal of Nephrology and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.